Immune system to fight brain tumors

Research at Lund University in Sweden gives hope that one of the most serious types of brain tumour, glioblastoma multiforme, could be fought by the patients' own immune system. The tumours are difficult to remove with surgery because the tumour cells grow into the surrounding healthy brain tissue. A patient with the disease therefore does not usually survive much longer than a year after the discovery of the tumour.

The team has tested different ways of stimulating the immune system, suppressed by the tumour, with a 'vaccine'. The vaccine is based on tumour cells that have been genetically modified to start producing substances that activate the immune system. The modified (irradiated so that they cannot divide and spread the disease) have been combined with other substances that form part of the body's immune system.

The treatment has produced good results in : 75 per cent of the rats that received the treatment were completely cured of their brain tumours.

"Human biology is more complicated, so we perhaps cannot expect such good results in patients. However, bearing in mind the patients receive today, all progress is important", said doctoral student Sara Fritzell, part of the research group led by consultant Peter Siesjö.

She has previously tested combining the activation of the immune system with chemotherapy. When the chemotherapy was applied directly to the tumour site, the positive effects reinforced each other, and a huge 83 per cent of the mice survived.

"Our idea is in the future to give patients chemotherapy locally in conjunction with the operation to remove as much of the tumour as possible", said Sara Fritzell.

Peter Siesjö is currently applying for permission to carry out a clinical study on stimulation of the immune system – with or without local chemotherapy – as a treatment for patients with glioblastoma multiforme.

Related Stories

Brain tumour cells killed by anti-nausea drug

date Mar 18, 2013

(Medical Xpress)—New research from the University of Adelaide has shown for the first time that the growth of brain tumours can be halted by a drug currently being used to help patients recover from the side effects of ...

Cancer treatment discovery opens tumours to immune cells

date May 28, 2012

(Medical Xpress) -- Scientists at the Western Australian Institute for Medical Research (WAIMR) have made exciting progress in their quest to help patients fight cancer using the body's own immune system.The ...

Virus-like particles provide vital clues about brain tumors

date Apr 17, 2013

Exosomes are small, virus-like particles that can transport genetic material and signal substances between cells. Researchers at Lund University, Sweden, have made new findings about exosomes released from aggressive brain ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

date 19 hours ago

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

date Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

date Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Timothy
May 31, 2013
There is another company who is fighting GBM by immunotherapy. The name of the company is Northwest Biotherapeutics and they have a product which is in Phase III, called DCVax-L. From earlier trials there are several patients who have been treated and who are still alive and in good shape after 10 years. In the US they currently have 47 trial locations and in in Europe they've received a priority phase 3 trial in the UK. The phase 3 trials is also eligible for compassionate use.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.